Bupropion (Zyban)

Bupropion (Zyban ) is a drug which has been licensed for use as an aid to quitting smoking.

It is taken as a two-month course of treatment, beginning one week before stopping smoking cigarettes. Bupropion can cause side-effects, such as insomnia, dry mouth, headache and fits. It also has antidepressant activity.

Bupropion interacts with anti-HIV drugs, namely with protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs), possibly requiring a dose alteration. It should not be taken with ritonavir (Norvir), although it is unclear whether this also applies when a small dose is used to boost another protease inhibitor. Because bupropion can cause fits, it should not be prescribed to anyone at risk of fitting.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.